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Summary
Changes in phenotype and function of gdT cells have been reported in inflam-
matory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative
colitis (UC). Dysregulation of lymphocyte migration plays a key role in IBD
pathogenesis; however, data on migratory properties of gd T cells are scarce.
Human circulating gd T cells from healthy controls (n = 27), patients with
active CD (n = 15), active UC (n = 14) or cutaneous manifestations of IBD
(n = 2) were characterized by flow cytometry. Circulating gd T cells in healthy
controls were CD3hi and expressed CD45RO. They expressed gut-homing
molecule b7 but not gut-homing molecule corresponding chemokine recep-
tors (CCR)9, or skin-homing molecules cutaneous lymphocyte-associated
antigen (CLA) and CCR4, despite conventional T cells containing populations
expressing these molecules. CCR9 expression was increased on gd T cells in
CD and UC, while skin-homing CLA was expressed aberrantly on gd T cells in
patients with cutaneous manifestations of IBD. Lower levels of CD3 expres-
sion were found on gd T cells in CD but not in UC, and a lower proportion of
gd T cells expressed CD45RO in CD and UC. Enhanced expression of gut-
homingmolecules on circulating gdT cells in IBD and skin-homingmolecules
in cutaneous manifestations of IBD may be of clinical relevance.
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Introduction
gd T cells are innate lymphocytes that constitute only a
minor T cell population in human peripheral blood, but are
enriched at epithelial sites such as the skin, lung and gut [1].
Epithelial tissue is constantly exposed to pathogenic micro-
organisms, toxic substances and inflammatory molecules;
one of the physiological functions of gd T cells may be
to control excessive inflammatory responses in epithelial
tissues. Indeed, murine dendritic epidermal T cells express-
ing a gd T cell receptor (TCR) are involved in the regulation
of epidermal integrity and promote wound repair of the skin
[2], whereas intestinal intraepithelial gd T (gd-IEL) cells
regulate intestinal epithelial homeostasis [3,4]. gd T cells can
down-regulate ab T cell responses which could otherwise
result in severe immunopathology [5]. gd T cells are also
important in immune surveillance of the epithelium by pro-
viding a first line of defence against infectious invading
pathogens, and regulating the bridge between innate and
adaptive immunity [5,6].
Ulcerative colitis (UC) and Crohn’s disease (CD), collec-
tively termed inflammatory bowel disease (IBD), result
from a dysregulated response of the mucosal immune
system to components of the luminal microbiota, and
breakdown of immune tolerance in individuals who are
genetically predisposed to the disease [7–9]. Many path-
ways are involved in the induction of chronic inflammation
in the gut mucosa in IBD. A role for gd T cells in IBD was
suggested originally by increased numbers of gd T cells
found in inflamed areas of the gut in humans with UC and
CD [10–13], but there is also growing evidence that gd T
cells play a role in co-ordinating innate and acquired
immune responses and maintaining the integrity of epithe-
lial tissues [2,4–6,14]. Data from murine studies are con-
flicting, with some demonstrating a protective role for gd T
cells in models of colitis [15–18], but others suggesting that
expansion and activation of gd T cells is essential for the
onset and aggravation of colitis [19–23].
Several mechanisms of immune dysregulation contribute
to IBD, including disruption of lymphocyte homing and
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migration patterns. Effector T cells migrating to intestinal
sites express high levels of the gut-homing molecule a4b7
[24], with its ligand human mucosal addressin cell adhesion
molecule-1 (MAdCAM-1) being expressed constitutively by
post-capillary endothelial cells in the small intestine [25] and
colonic lamina propria [26]. Interactions between a4b7 and
MAdCAM-1 are key mediators of lymphocyte homing to
intestinal sites [27]. In addition, interaction of chemokines
such as CCL25 (TECK), with their corresponding chemok-
ine receptors (CCR9), contribute to homing to the small
intestine [28]. In animal models of colitis, expression
of MAdCAM-1 is up-regulated in the intestinal lamina
propria, and anti-MAdCAM-1 or a4b7 treatment results in
reduced lymphocyte recruitment to the intestine [29–33].
MAdCAM-1, a4b7 and CCR9 expression are also dysregu-
lated in humans with IBD [34–37].
Distribution patterns of circulating gd T cells in peripheral
tissues have not been well described, although the major
blood subset of gd T cells in macaques can enter the gut
mucosa readily upon activation [38]. Although the mecha-
nisms of specific recruitment of gd T cells to the gut mucosa
are unclear, human gd T cells express CXCR3 [39], which
binds chemokines CXCL9, CXCL10 and CXCL11, produced
by local cells in inflammatory lesions. gd T cells may be
recruited to the gut mucosa by this method under inflam-
matory intestinal conditions; indeed, CXCR3 expression has
been implicated in coeliac disease [40]. Similarly, human
circulating gd T cells can also express lymphocyte function-
associated antigen (LFA)-1 [41], which recognizes intercel-
lular adhesion molecule-1 (ICAM-1) [42], expressed by
epithelial cells [43]. ICAM-1 expression is increased under
inflammatory conditions [44] and tissue stress [45]. CCR2
expression has been implicated in gd T cell trafficking during
inflammation [46], although gd T cells have yet to be defined
for molecules involved in recruitment to the gut mucosa
specifically.
IBD is associated with a variety of extra-intestinal
manifestations (EIM), with up to a third of IBD patients
developing cutaneous manifestations, including erythema
nodosum (EN) and pyoderma gangrenosum (PG) [47]. The
causes of EIM of IBD are poorly understood, but it has been
suggested that compartmentalization of inflammatory pro-
cesses to different organs (e.g. intestines, skin, liver) may be
linked to homing and trafficking of immune cells. For
example, CCL25, the ligand for gut-homing receptor CCR9,
is expressed on epithelium in both the liver and the small
intestine [48]. Skin T cells express E- and P-selectin ligands,
including cutaneous lymphocyte-associated antigen (CLA)
[49], thought to be involved in tissue-specific localization of
cutaneous T cells within the skin [50]. Interaction between
chemokine receptors CCR4 and CCR10 and their respective
ligands CCL17 and CCL27 have also been implicated in skin-
homing [51]; expression of skin-homing molecules may be
dysregulated on immune cells in cutaneous manifestations
of IBD.
The homing profile of gd T cells has yet to be characterized
in either healthy controls or IBD patients. We aimed to char-
acterize the homing profile of human, circulating gd T cells
in healthy controls and to compare this profile to that of
patients with active IBD.
Materials and methods
Human blood samples
Peripheral blood (20 ml) was collected into heparinized
Vacutainer tubes (BD Biosciences, Oxford, UK) following
informed consent (EC numbers 05/Q0405/71 and
08/H0717/24). Blood was obtained from healthy controls
(n = 27; 12 female and 15 male; mean age 35 years) or from
patients with active CD (n = 15; eight female and seven male;
mean age 43 years) or UC (n = 14; six female and eight male;
mean age 38 years). Diagnosis for patients with active CD
and UC was made using clinical parameters, radiographic
studies, endoscopic and histological criteria. Disease activity
for UC was assessed using the UC disease activity index
(UCDAI); all patients had a UCDAI > 4. Disease activity for
CD was assessed using the CD activity index (CDAI); all
patients had a CDAI > 220. All UC patients had pancolitis;
CD patients were comprised of a mixture of Crohn’s colitis
(n = 4), small bowel CD only (n = 5), or both colonic and
small bowel involvement (n = 6). Patients were either
not receiving therapy or were on minimal treatment:
5-aminosalicylic acid (5-ASA) and/or azathioprine (AZA).
Peripheral blood mononuclear cells (PBMC) were obtained
by centrifugation over Ficoll-Paque Plus (Amersham Bio-
sciences, Chalfont St Giles, UK).
Antibody labelling
Monoclonal antibodies with the following specificities
and conjugations were used: CLA-fluorescein isothiocya-
nate (FITC) (HECA-452), CD103-FITC (Ber-ACT8),
b7 integrin-phycoerythrin (PE) (FIB504), CD45RO-PE
(UCHL1), CD3-peridinin chlorophyll cyanin 5·5 (Per-
CPCy5·5) (SK7), CD3-PECy5 (UCHT1), CLA-biotin
(HECA-452) and strepavidin–allophycocyanin (APC) were
purchased from BD Biosciences (Oxford, UK); CCR9 (either
FITC- or APC-conjugated) (112509), CCR7-PE (150503),
CCR10-APC (314315), CCR7-PE (150503) and CCR4-APC
(205410) were purchased from R&D Systems (Abingdon,
UK); appropriate isotype-matched control antibodies were
purchased from the same manufacturers. After antibody
labelling, cells were fixed with 1% paraformaldehyde in
0·85% saline and stored at 4°C prior to acquisition on the
flow cytometer, within 48 h.
Flow cytometry and data analysis
Data were acquired on a fluorescence activated cell sorter
(FACS)Calibur cytometer (BD Biosciences) and analysed
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using WinList 5·0 software (Verity, Topsham, ME, USA). T
cells were identified as CD3+ lymphocytes within the PBMC
population, and gd T cells were identified as CD3+ lympho-
cytes expressing a gd T cell receptor (TCR). The proportion
of cells positive for a given marker was determined by refer-
ence to staining with an isotype-matched control antibody.
WinList was used to subtract the normal cumulative histo-
gram for isotype control staining from a similar histogram of
staining with the test antibody using the superenhanced Dmax
(SED) normalized subtraction.
Statistical analyses
Statistical analyses were carried out using GraphPad Prism
software (GraphPad SoftwareTM, San Diego, CA, USA).
Pooled data are expressed as mean values standard error;
t-tests (paired and non-paired) were applied as stated in the
figure legends. P < 0·05 was considered significant.
Results
Human circulating gd T cells were CD3hi
Human circulating gd T cells were identified by flow cytom-
etry as CD3+ lymphocytes expressing a gd TCR (Fig. 1a).
Upon analysis of expression levels of CD3 per cell, measured
via the mean fluorescence intensity (MFI) of CD3 staining,
circulating gd T cells were CD3hi in healthy controls, i.e.
expressed a higher mean level of CD3 per cell than the total
circulating T cell population (Fig. 1b).
Human circulating gd T cells expressed gut-homing
marker b7 but not skin-homing markers
Expression of specific tissue-homing molecules on gd T cells
in peripheral blood, in particular skin- and gut-homing
markers, were investigated. In healthy controls, the majority
of circulating gd T cells expressed gut-homing molecule b7
integrin, although expression of CCR9, a chemokine recep-
tor involved in migration towards the small bowel, was
minimal. b7 was expressed by a large fraction of the total T
cell population, but a significantly greater proportion of cells
expressed this gut-homing marker within the gd T cell subset
(Fig. 2a). Total T cells in healthy controls lacked CCR9+ cells
(small bowel-homing) and included few CCR10+ cells (skin-
associated migration), but incorporated significant numbers
of CLA+ and CCR4+ ‘skin-homing’ cells. In contrast, circu-
lating gd T cells lacked putative ‘skin-homing’ subsets in
healthy control blood (Fig. 2b).
Levels of CD3 were decreased on gd T cells
in Crohn’s disease
Circulating gd T cells in healthy controls were CD3hi, but
circulating gd T cells in patients with active CD expressed a
significantly lower level of CD3 (CD3med cells; Fig. 3a,b),
while gd T cells from patients with active UC expressed com-
parable levels of CD3 to gd T cells from healthy controls
(Figs 1b and 3b).
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Fig. 1. Identification of human circulating gd T cells and levels of CD3 expression. (a) Identification of gd T cells from peripheral blood
mononuclear cells (PBMC) according to fluorescence activated cell sorter (FACS) plots of forward- and side-scatters, and subsequent CD3
histogram and gd T cell receptor (TCR) histogram. This example is from a healthy control. gd T cells comprised 5·2 0·9% (n = 27) of the total
circulating T cell population. (b) FACS histograms demonstrating gd T cells (red) back-gated onto the CD3 peak using WinListTM software, and
summary graphs demonstrating mean fluorescence intensity (MFI) of CD3 staining of total circulating T cells compared with gd T cells (n = 27).
Histograms are representative of 27 independent experiments and were compared to isotype-matched controls. Paired t-test was applied. A
P-value < 0·05 was considered statistically significant (*P < 0·05; **P < 0·01; ***P < 0·001).
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Gut-homing marker CCR9 was increased on gd T cells
in Crohn’s disease and ulcerative colitis
gd T cells from healthy controls and patients with active CD,
and active UC (no cutaneous manifestations) did not express
skin-homing markers CLA, CCR4 or CCR10, and there were
no differences in expression of gut-homing marker b7
between the two groups (data not shown). However, there
was a significant increase in the proportion of gd T cells
expressing gut-homing marker CCR9 in both CD and UC,
compared with gd T cells from healthy controls (Fig. 4). This
increase in CCR9 expression was not evident in the total
circulating T cell population (data not shown).
CD45RO expression was decreased on gd T cells in
Crohn’s disease and ulcerative colitis
The majority of circulating gd T cells display a pre-activated
phenotype characterized by the expression of ‘memory
marker’ CD45RO, allowing rapid induction of effector func-
tions following detection of tissue stress [52]. We hypoth-
esized that gd T cell expression of CD45RO may be altered in
IBD due to the chronic inflammation and tissue stress in the
gut mucosa in IBD. Assessment of CD45RO expression on
circulating T cells in healthy controls confirmed that the
majority of gd T cells in blood expressed CD45RO, but
CD45RO expression was reduced significantly on gd T cells
from blood of patients with CD and UC without cutaneous
manifestations, compared with healthy controls (Fig. 5).
This change was not evident among the total circulating T
cell pool (data not shown).
Because gd T cells can up-regulate expression of lymph-
node homing marker CCR7 upon activation [53], we
hypothesized that gd T cell expression of CCR7 may also be
altered in IBD. CCR7 expression was variable on gd T cells
from healthy controls (range 0–46·4%), but expression of
CCR7 on gd T cells was unaltered in CD or UC without
cutaneous manifestations (data not shown).
Unique population of skin-homing gd T cells
in cutaneous manifestations of inflammatory
bowel disease
The homing profiles of gd T cells in two patients with skin
manifestations of IBD were also analysed. EN is one of the
more common cutaneous manifestations of IBD, the causes
Fig. 2. Expression of gut- and skin-homing
markers on gd T cells. (a) Fluorescence
activated cell sorter (FACS) histograms
demonstrating proportions of gd T cells
expressing b7 (93·9 1·5%, n = 16) and
corresponding chemokine receptor (CCR)9
(3·8 1·4%, n = 11); comparison against total
circulating T cells for expression of b7
(77·0 1·3%, n = 16). (b) FACS histograms
demonstrating proportions of gd T cells
expressing cutaneous lymphocyte-associated
antigen (CLA) (0·8 0·3%, n = 9), CCR4
(1·6 0·6%, n = 8) and CCR10 (0·2 0·1%,
n = 5); comparison against total circulating T
cells for expression of CLA (12·6 1·8%,
n = 15) and CCR4 (16·9 1·6%, n = 10).
Histograms are representative of several
independent experiments performed with
similar results and were compared to
isotype-matched controls; t-test was applied.
A P-value < 0·05 was considered statistically
significant (*P < 0·05; **P < 0·01; ***P < 0·001).
Error bars represent standard error of the
mean, horizontal lines represent the mean.
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of which are poorly understood, but the occurrence of EN is
rare. In light of the extensive data collected in healthy con-
trols and in IBD patients without EN with negligible expres-
sion of CLA and low standard errors, we considered two EN
samples to be informative.
Although expression of skin-homing marker CLA was neg-
ligible on gdT cells in both healthy controls and patients with
active IBD without EN, aberrant expression of CLA on gd T
cells was detected in patients with IBD and EN. This unique
population of CLA+ gd T cells in EN did not express the
gut-homing marker b7 integrin, suggesting that this small
population of cells were skin-homing gd T cells (Fig. 6a).
Expression of other tissue-homing markers on gd T cells was
unaffected, including gut-homing markers b7 and CCR9 and
skin-homing markers CCR4 and CCR10 (data not shown).
Finally, an EN patient administered oral corticosteroids
(prednisolone, 40 mg daily) underwent rapid resolution of
the EN and improvement in general wellbeing (Fig. 6b). Fol-
lowing corticosteroid administration, the CLA+b7– abnormal
skin-homing gd T cell population was no longer detected in
the circulation; circulating gd T cells were CLA–b7+ (Fig. 6a).
Discussion
We demonstrate for the first time that circulating gd T cells
in the steady state express gut-homing marker b7 but do not
express molecules enabling migration towards cutaneous
sites. gd T cells have not been analysed previously for expres-
sion of molecules involved in cell trafficking in the context of
IBD. In this study, we identified and characterized gd T cells
exhibiting dysregulation of their homing properties; a subset
of altered gut-homing gd T cells was detected in both CD and
UC, and a subset of skin-homing gd T cells was present in EN
(a cutaneous manifestation of IBD).
In contrast to rapid recruitment of effector lymphocytes
to sites of inflammation [27], the mechanisms controlling
steady state traffic of T cells and their maintenance within
healthy tissue are not well understood [54–57]. Although
human circulating gd T cells did not express skin-homing
markers or gut-homing marker CCR9 in the steady state,
the majority expressed b7 gut-homing integrin.b7 combines
with a4 integrin to allow leucocytes to enter intestinal
tissue via interactions with MAdCAM-1 [25,26,58]. While
Fig. 3. Reduced CD3 levels on gd T cells in
Crohn’s disease but not ulcerative colitis. (a)
Fluorescence activated cell sorter (FACS)
histograms demonstrating levels of CD3
expression via gd T cells (red) back-gated onto
the CD3 peak using WinListTM software in
healthy controls, active Crohn’s disease (CD)
patients and active ulcerative colitis (UC)
patients. Histograms are representative of
several independent experiments. (b) Summary
graphs demonstrating mean fluorescence
intensity (MFI) of CD3 staining of total
circulating T cells compared with gd T cells in
active CD patients (n = 8) and active UC
patients (n = 9), and summary graph
demonstrating ratio of gd T cell CD3 mean
fluorescence intensity (MFI): total T cells CD3
MFI in healthy controls (1·6 0·1, n = 16),
active CD (1·2 0·1, n = 8) and active UC
(1·6 0·2, n = 9). For comparison of total T
cells versus gd T cells CD3 MFI within the same
individuals, paired t-tests were applied. For
comparison of gd T cell : total T cell CD3 MFI
ratios between healthy controls, active CD and
active UC patients, unpaired t-tests were
applied. A P-value < 0·05 was considered
statistically significant (*P < 0·05; **P < 0·01;
***P < 0·001; ***P < 0·001). Error bars
represent standard error of the mean,
horizontal line represents the mean.
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circulating T cells can be either gut-homing or skin-homing
[51,59], in the current report we demonstrate that circulat-
ing gd T cells are mainly gut-homing. These data may reflect
the suggested role for gd T cells in intestinal homeostasis
[3,4] and support studies demonstrating that the major
blood subset of gd T cells in primates (Vg2 Vd2 T cells) can
enter the gut mucosa readily upon activation [38].
The current report is consistent with previous studies
demonstrating changes in the phenotype and function of
human gd T cells in skin inflammation [60,61] and in IBD
[11]. The increased expression of skin-homing molecule
CLA on gd T cells in EN and enhanced gut-homing receptor
CCR9 expression on gd T cells in CD and UC without cuta-
neous manifestations may reflect the recruitment of gd T
cells from the circulation to the inflamed skin and gut,
respectively. Indeed, homing of gd T cells to intestinal sites is
impaired in CCR9-deficient mice [62] and a role for skin-
homing gd T cells has been reported in inflammatory skin
disease [63].
The alterations in CCR9 expression in IBD without any
observed changes in gut-homing b7 expression may be due
to the inherently high expression of b7 on gd T cells in
healthy controls. Our previous studies have demonstrated
that b7 is found not only on T cells from the human gut,
but also from the blood and skin. The differences in
T cell homing profiles between these tissues was due to
co-expression with other homing molecules and chemokine
receptors [59]. Although CCR9 contributes to leucocyte
homing to the small bowel in particular [28], patients exhib-
iting enhanced CCR9 expression on gd T cells in this study
included those with UC and Crohn’s colitis, suggesting
either a role for CCR9 in the colon or the existence of immu-
nological changes in the small bowel in these diseases,
despite the lack of any presenting small bowel symptoms.
The CD3hi phenotype of gd T cells in healthy controls may
reflect the pre-activated status of circulating gd T cells to
allow rapid effector functions; indeed, CD45RO expression
on gd T cells enables rapid effector functions following tissue
stress and bacterial infections [52]. The reduction of CD3
levels in CD and reduced CD45RO expression in CD and UC
may be a result of chronic activation of the immune system;
chronic infections can reduce expression of TCR chains
[64–66] likely to affect associated co-receptors such as CD3
[67]. gd T cells lost CD45RO expression following viral infec-
tion in cattle [68,69].
The population of gd T cells that we have studied, circu-
lating gd T cells, are comprised mainly of Vg2 Vd2 T cells that
exist only in primates and humans [70]. Vg2 Vd2 T cells are
linked typically with anti-microbial immune responses
[70,71] and IBD results from a dysregulated immune
response to components of the luminal microbiota [7–9]. As
Vg2 Vd2 cells can enter the gut mucosa readily upon activa-
tion [38], it is therefore possible that a dysregulated response
of circulating Vg2 Vd2 T cells to the microbiota occurs in the
gut and the skin in IBD and EN, respectively, or alternatively
that gd T cells are recruited from the circulation to sites of
inflammation to promote homeostasis at these sites.
Conclusions
Further work will be necessary to determine the functional
role of gd T cells in IBD and cutaneous manifestations of
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Fig. 4. Increased proportion of corresponding chemokine receptors
(CCR)9+ gd T cells in Crohn’s disease (CD) and ulcerative colitis
(UC). Proportions of circulating gd T cells in healthy controls
(3·8 1·4%, n = 11), active CD patients (27·4 5·9, n = 8) and active
UC patients (21·4 9·2%, n = 7) expressing gut-homing marker
CCR9; t-test was applied. A P-value < 0·05 was considered statistically
significant (*P < 0·05; **P < 0·01; ***P < 0·001). Error bars represent
standard error of the mean, horizontal lines represent mean.
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Fig. 5. Reduced proportion of CD45RO+ gd T cells in Crohn’s disease
(CD) and ulcerative colitis (UC). Proportions of circulating gd T cells
in healthy controls (69·8 4·4%, n = 22), active CD patients
(31·4 6·2%, n = 15) and active UC patients (32·1 4·5%, n = 15)
expressing CD45RO; t-test was applied. A P-value < 0·05 was
considered statistically significant (***P < 0·001). Error bars represent
standard error of the mean, horizontal lines represent mean.
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IBD, but the dysregulation of gd T cell homing profiles in
these diseases is likely to be clinically relevant. Oral corticos-
teroids led to rapid resolution of EN, accompanied by
removal of the unique skin-homing population of gd T cells
from the circulation. Targeting tissue-homing pathways pro-
vides a more specific approach to IBD therapy, and allows for
selective anti-inflammatory treatments. For instance, a4b7
inhibitor MLN-O2 [72] and CCR9 inhibitor Traficet-EN
[73] have efficacy in IBD. These data suggest that homing
profiles could potentially be used as markers for active
inflammation at particular sites in IBD and in cutaneous
manifestations of IBD.
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